Business | Press Trust of India | Monday April 20, 2015
In December 2014, Fresenius Kabi had filed a suit against Claris Lifesciences to block commercialisation of its abbreviated new drug application (ANDA) for Propofol, used to induce or maintain anesthesia during surgeries.
www.ndtv.com/business